Candesant Biomedical Funding: $35M Raised, Series B (2023)
Candesant Biomedical is based in San Francisco, California. It has raised $35M in total funding. Latest round: Series B.
Candesant Biomedical funding overview
Candesant Biomedical is based in San Francisco, California. Candesant Biomedical has raised $35M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in June 2023. The round record for Candesant Biomedical runs through 2023; nothing later has been disclosed. Investors on record include KCK MedTech, Polaris Partners, Astia Fund, Correlation Ventures. 4 distinct backers are named across the disclosed rounds.
Frequently asked about Candesant Biomedical funding
How much has Candesant Biomedical raised?
Candesant Biomedical has raised $35M in total disclosed funding across the rounds on record.
Who has invested in Candesant Biomedical?
KCK MedTech, Polaris Partners, Astia Fund, Correlation Ventures are named among the investors backing Candesant Biomedical.
What was the latest Candesant Biomedical funding round?
The most recent disclosed round is a Series B, announced in June 2023.
Where is Candesant Biomedical based?
Candesant Biomedical is based in San Francisco, California.
When did Candesant Biomedical last raise?
The last disclosed Candesant Biomedical round closed in June 2023 at Series B.
Candesant Biomedical totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in San Francisco below to benchmark round size and investor mix.
